You are here:

dapoxetine (Priligy)

Advice

in the absence of a submission from the holder of the marketing authorisation

dapoxetine hydrochloride (Priligy®) is not recommended for use within NHS Scotland.

Indication under review: treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: dapoxetine (Priligy)
SMC Drug ID: 987/14
Manufacturer: A Menarini Pharmaceuticals UK Ltd
Indication: Treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.
BNF Category:
Sub Category: 7.4 Drugs for genito-urinary disorders
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 July 2014

Back